{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:24:12Z","timestamp":1789082652724,"version":"build-2803163510"},"reference-count":47,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T00:00:00Z","timestamp":1454630400000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2016,2]]},"abstract":"<jats:p>Preconception care refers to a set of interventions that identify and address biomedical, behavioral, and social risks to a woman's health that may negatively impact a future pregnancy. A great need for preconception care currently exists in the United States, and women's attitudes about discussions with health care providers about healthy and safe pregnancies are positive. Clinical pharmacists are well positioned to work with other health care and public health professionals to ensure that all women of childbearing potential have access to preconception care. As part of the collaborative health care team, clinical pharmacists can directly provide services or support and referrals to other members of the health care team or to community resources through clinical\u2010community linkages. Specifically, clinical pharmacists can provide education, counseling, and\/or services to women to address family planning, medication and disease state management, immunizations, screenings, health promotion, and substance use. Clinical pharmacists can also impact preconception care through drug information services, advocacy, and research. Preconception care services can be incorporated into daily pharmacy practice, and there are potential means for reimbursement. Multiple roles exist for clinical pharmacists to fulfill unmet needs in preconception care.<\/jats:p>","DOI":"10.1002\/phar.1691","type":"journal-article","created":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T02:32:13Z","timestamp":1454639533000},"page":"141-151","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Fulfilling an Unmet Need: Roles for Clinical Pharmacists in Preconception Care"],"prefix":"10.1002","volume":"36","author":[{"given":"Natalie A.","family":"DiPietro Mager","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice Raabe College of Pharmacy Ohio Northern University Ada Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,2,5]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"1","article-title":"Recommendations to improve preconception health and health care\u2014United States: a report of the CDC\/ATSDR Preconception Care Work Group and the Select Panel\u00a0on Preconception Care","volume":"55","author":"Centers for Disease Control and Prevention","year":"2006","journal-title":"MMWR Surveill Summ"},{"key":"e_1_2_7_3_1","unstructured":"KentH JohnsonK CurtisM RichardsonJ AtrashH Proceedings of the preconception health and health care clinical public health and consumer workgroup meetings. Centers for Disease Control and Prevention; June 27\u201328 2006; Atlanta GA. Available fromhttp:\/\/www.cdc.gov\/preconception\/documents\/WorkgroupProceedingsJune06.pdf. Accessed January 16 2016."},{"key":"e_1_2_7_4_1","unstructured":"Centers for Disease Control and Prevention.Preconception health and health care: clinical content for women. Available fromhttp:\/\/www.cdc.gov\/preconception\/careforwomen\/index.html. Accessed January 16 2016."},{"issue":"3","key":"e_1_2_7_5_1","first-page":"397","article-title":"Recommendations for preconception care","volume":"76","author":"Lu MC","year":"2007","journal-title":"Am Fam Physician"},{"key":"e_1_2_7_6_1","unstructured":"Guttmacher Institute.Unintended pregnancy in the United States 2013. Available fromhttp:\/\/www.guttmacher.org\/pubs\/FB-Unintended-Pregnancy-US.html. Accessed January 16 2016."},{"key":"e_1_2_7_7_1","unstructured":"World Health Organization.Preconception care: maximizing the gains for maternal and child health 2014. Available fromhttp:\/\/www.who.int\/maternal_child_adolescent\/documents\/preconception_care_policy_brief.pdf. Accessed January 16 2016."},{"key":"e_1_2_7_8_1","unstructured":"MacDormanMF MathewsTJ MohangooAD ZeitlinJ.International comparisons of infant mortality and related factors: United States and Europe 2010. National Vital Statistics Report 2014. Available fromhttp:\/\/www.cdc.gov\/nchs\/data\/nvsr\/nvsr63\/nvsr63_05.pdf. Accessed January 16 2016."},{"key":"e_1_2_7_9_1","doi-asserted-by":"crossref","unstructured":"American Congress of Obstetricians and Gynecologists.The importance of preconception care in the continuum of women's health care. ACOG Committee Opinion No. 313. Obstet Gynecol2005;106:665\u20136. Available fromhttp:\/\/www.acog.org\/Resources-And-Publications\/Committee-Opinions\/Committee-on-Gynecologic-Practice\/The-Importance-of-Preconception-Care-in-the-Continuum-of-Womens-Health-Care#resources. Accessed January 16 2016.","DOI":"10.1097\/00006250-200509000-00052"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.07.067"},{"issue":"1","key":"e_1_2_7_11_1","doi-asserted-by":"crossref","DOI":"10.24926\/iip.v5i1.323","article-title":"Medication therapy management and preconception care: opportunities for pharmacist intervention","volume":"5","author":"DiPietro NA","year":"2014","journal-title":"Innov Pharm"},{"key":"e_1_2_7_12_1","unstructured":"DiPietro MagerNA BrightDR.Delivering preconception medication therapy management services in the community pharmacy. Available fromwww.raabecollegeofpharmacy.org\/mtm. Accessed January 16 2016."},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2014.14536"},{"issue":"4","key":"e_1_2_7_14_1","first-page":"394","article-title":"Identifying women who might benefit from higher doses of folic acid in pregnancy","volume":"58","author":"Kennedy D","year":"2012","journal-title":"Can Fam Physician"},{"key":"e_1_2_7_15_1","volume-title":"Office of Disease Prevention and Health Promotion. Healthy People 2020","author":"U.S. Department of Health and Human Services"},{"issue":"03","key":"e_1_2_7_16_1","first-page":"1","article-title":"Core state preconception health indicators\u2014pregnancy risk assessment monitoring system and behavioral risk factor surveillance system, 2009","volume":"63","author":"Robbins CL","year":"2014","journal-title":"MMWR Surveill Summ"},{"issue":"4","key":"e_1_2_7_17_1","first-page":"264","article-title":"Trends in contraceptive and preconception care in United States ambulatory practices","volume":"47","author":"Bello JK","year":"2015","journal-title":"Fam Med"},{"key":"e_1_2_7_18_1","volume-title":"Improving preconception health: women's knowledge and use of folic acid","author":"Gallup Organization and March of Dimes Foundation","year":"2008"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10995-009-0518-6"},{"key":"e_1_2_7_20_1","unstructured":"Agency for Healthcare Research and Quality.Clinical\u2010community linkages. Available fromhttp:\/\/www.ahrq.gov\/professionals\/prevention-chroniccare\/improve\/community\/index.html. Accessed January 16 2016."},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2011.09.011"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2010.09195"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.15.1809"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1457"},{"key":"e_1_2_7_25_1","unstructured":"National Conference of State Legislatures.Emergency contraception state laws August 2012. Available fromhttp:\/\/www.ncsl.org\/research\/health\/emergency-contraception-state-laws.aspx. Accessed January 16 2016."},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2008.07138"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2007.06112"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.01.013"},{"key":"e_1_2_7_29_1","unstructured":"OstrovBF.California Oregon to allow hormonal contraceptives without a doctor's prescription. Kaiser Health News July 2015. Accessed January 16 2016."},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2014.14045"},{"key":"e_1_2_7_31_1","unstructured":"Centers for Disease Control and Prevention.Media campaigns: implementation kit April 2002. Available fromwww.cdc.gov\/ncbddd\/folicacid\/documents\/mediacampaignkit.pdf. Accessed January 16 2016."},{"key":"e_1_2_7_32_1","first-page":"15","volume-title":"Diseases, complications, and drug therapy in obstetrics: a guide for clinicians","author":"Briggs GG","year":"2009"},{"key":"e_1_2_7_33_1","unstructured":"HutterC.What's behind NYC's drastic decrease in infant mortality rates? April 2015. National Institute for Children's Health Quality. Available fromhttp:\/\/www.nichq.org\/blog\/2015\/april\/nyc-infant-mortality# sthash.qYF9Cgmc.dpuf. Accessed January 16 2016."},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.31.4.424"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000423818.85283.bd"},{"key":"e_1_2_7_36_1","unstructured":"American Medical Association Committee Resolution D\u201075.995: Over\u2010the\u2010counter access to oral contraceptives.2013. Available fromhttps:\/\/www.ama-assn.org\/ssl3\/ecomm\/PolicyFinderForm.pl?site=www.ama-assn.org&uri=%2fresources%2fhtml%2fPolicyFinder%2fpolicyfiles%2fDIR%2fD-75.995.HTMAccessed January 16 2016."},{"key":"e_1_2_7_37_1","unstructured":"American Academy of Family Physicians (AAFP) Resolution: The AAFP supports over\u2010the\u2010counter access to oral contraception without a prescription 2014. Available fromhttp:\/\/www.aafp.org\/about\/policies\/all\/otc-oral-contraceptives.html. Accessed January 16 2016."},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1438"},{"key":"e_1_2_7_39_1","unstructured":"International Pharmaceutical Federation.The effective utilization of pharmacists in improving maternal newborn and child health. 2013 Available from fip.org\/files\/fip\/publications\/FIP_Statement_of_Policy_MNCH_2013_Final.pdf. Accessed January 16 2016."},{"key":"e_1_2_7_40_1","unstructured":"American College of Clinical Pharmacy.Practice and Research Networks 2014. Available fromhttp:\/\/www.accp.com\/about\/prns.aspx. Accessed January 16 2016."},{"key":"e_1_2_7_41_1","unstructured":"Wisconsin Association for Perinatal Care Association.Planning for a healthy future: algorithm for providers caring for women of childbearing age. Available fromhttp:\/\/perinatalweb.org\/assets\/cms\/uploads\/files\/WAPC%20Algorithm_2015_FINAL_v2_locked.pdf. Accessed January 16 2016."},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1563"},{"key":"e_1_2_7_43_1","unstructured":"GebhartF.Pharmacist provider status gains traction. Drug Topics March 2015. Available fromhttp:\/\/drugtopics.modernmedicine.com\/drug-topics\/news\/pharmacist-provider-status-gainstraction?page=full. Accessed January 16 2016."},{"key":"e_1_2_7_44_1","unstructured":"NutescuEA.Current billing models: clinical pharmacy services. Available fromhttp:\/\/www.ashp.org\/doclibrary\/membercenter\/webinars\/webinar20080814.aspx. Accessed January 16 2016."},{"key":"e_1_2_7_45_1","unstructured":"U.S. Department of Health and Human Services. Preventive services covered under the Affordable Care Act September 2010. Available fromhttp:\/\/www.hhs.gov\/healthcare\/facts\/factsheets\/2010\/07\/preventive-services-list.html. Accessed January 16 2016."},{"key":"e_1_2_7_46_1","unstructured":"Association of Maternal and Child Health Programs.Opportunities and strategies for improving preconception health through health reform March 2015. Available fromhttp:\/\/www.amchp.org\/Transformation-Station\/Documents\/AMCHP%20Preconception%20Issue%20Brief.pdf?utm_source=PCHHC+May+2015+Newsletter&utm_campaign=PCHHC+May+2015&utm_medium=email. Accessed January 16 2016."},{"issue":"9","key":"e_1_2_7_47_1","first-page":"14","article-title":"CareSource announces payment for pharmacist\u2010provided MTM for Ohio Medicaid patients","volume":"61","author":"Vyzral K","year":"2012","journal-title":"Ohio Pharm"},{"key":"e_1_2_7_48_1","unstructured":"YapD.Washington state implements Medicaid managed care MTM law for 2015 June 2014. Available fromhttps:\/\/www.pharmacist.com\/washington-state-implements-medicaid-managed-care-mtm-law-2015. Accessed January 16 2016."}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fphar.1691","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.1691","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:01:54Z","timestamp":1761040914000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/phar.1691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.1002\/phar.1691"],"URL":"https:\/\/doi.org\/10.1002\/phar.1691","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"2016-02-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}